A detailed history of Cullen Investment Group, Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Cullen Investment Group, Ltd. holds 8,630 shares of AMGN stock, worth $2.27 Million. This represents 0.41% of its overall portfolio holdings.

Number of Shares
8,630
Previous 8,607 0.27%
Holding current value
$2.27 Million
Previous $2.69 Billion 3.4%
% of portfolio
0.41%
Previous 0.43%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 04, 2024

BUY
$309.38 - $337.38 $7,115 - $7,759
23 Added 0.27%
8,630 $2.78 Billion
Q2 2024

Jul 01, 2024

SELL
$262.75 - $319.31 $20,231 - $24,586
-77 Reduced 0.89%
8,607 $2.69 Billion
Q1 2024

Apr 04, 2024

SELL
$268.87 - $324.56 $1,344 - $1,622
-5 Reduced 0.06%
8,684 $2.4 Billion
Q4 2023

Jan 30, 2024

BUY
$255.7 - $288.46 $2.22 Million - $2.51 Million
8,689 New
8,689 $2.5 Billion

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $140B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Cullen Investment Group, Ltd. Portfolio

Follow Cullen Investment Group, Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cullen Investment Group, Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Cullen Investment Group, Ltd. with notifications on news.